星球日报|11月 17, 2026 14:42
[Drug Developer Sellas Life Sciences Surges 220% at Open] According to MSX.COM data, drug developer Sellas Life Sciences surged 220% at the open after the company announced on Tuesday that its experimental vaccine for a blood cancer had yielded positive results in a late-stage clinical trial, significantly extending patients' survival time.
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink